Infinant Health Revenue and Competitors

Davis, CT USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Infinant Health's estimated annual revenue is currently $5.1M per year.(i)
  • Infinant Health's estimated revenue per employee is $155,000

Employee Data

  • Infinant Health has 33 Employees.(i)
  • Infinant Health grew their employee count by -49% last year.

Infinant Health's People

NameTitleEmail/Phone
1
Office Manager/ Executive Assistant to CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Marketing OfficerReveal Email/Phone
4
Chief Science OfficerReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Chief Marketing OfficerReveal Email/Phone
7
SVP Finance and ControllerReveal Email/Phone
8
VP, Clinical ImplementationReveal Email/Phone
9
Director, Business Operations and AnalyticsReveal Email/Phone
10
Executive Director, Regulatory Affairs and Intellectual PropertyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-80%N/AN/A
#2
$4.3M288%N/AN/A
#3
$9.8M66-11%N/AN/A
#4
$1.4M9350%N/AN/A
#5
$16.6M107-23%N/AN/A
#6
$4.5M29-22%N/AN/A
#7
$1.7M1157%N/AN/A
#8
$2.3M15-6%N/AN/A
#9
$0.3M4-43%N/AN/A
#10
$4M260%N/AN/A
Add Company

What Is Infinant Health?

Infinant Health, Inc is a privately held company committed to changing the trajectory of human health, one baby at a time, through our deep understanding of infant nutrition and the gut microbiome. Years of proprietary research into the role of human milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to unintended consequences of modern medicine such as feeding and birthing practices. Now, there is a way to change that. What we found is that EVC001, our specific strain of B. infantis, is essential in developing a healthy microbiome, reducing potential harmful bacteria that may be linked to prevalent childhood issues such as allergies and type 1 diabetes, moderating inflammation, and supporting healthy immune system function. We believe the greatest chance to impact future health begins early, right after birth—a once in a lifetime opportunity where rapid development and radical changes occur. By unlocking human nutrition's full potential through introducing beneficial bacteria during early infancy, we can help build a foundation for better health.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

-49%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.7M33-6%N/A
#2
$3.8M3310%N/A
#3
$3.5M333%N/A
#4
$5.5M333%N/A
#5
$5.1M333%N/A